Portugal · European Pharmaceutical Market
Engineered for precision.
A high-specification biofactory platform for consistent, compliant, pharmaceutical-grade supply.
LUAR DO CÔA / MOONLIGHT OVER THE CÔA
01 / About
A precise platform for a regulated European market.
LVX BioTech is developing an EU-GMP certified medicinal cannabis cultivation and processing facility in Portugal’s Beiras e Serra da Estrela region. Currently in the pre-licensing phase, we are building for the exacting requirements of the European pharmaceutical market. LVX BioTech is part of the Luar do Côa group; its name—moonlight over the Côa—honours the founding partners’ family roots in Portugal’s Côa valley. The circular mark is a quiet nod to that heritage.
02 / What We Do
An integrated, compliance-led supply platform.
Indoor GACP Cultivation
Controlled-environment cultivation designed around repeatability, traceability, and crop integrity.
GMP-Certified Processing & Extraction
A processing pathway planned for quality-controlled pharmaceutical formulations and extract handling.
EU Market Access & Distribution
A partner-ready platform for regulated access to specialist pharmaceutical channels across Europe.
03 / Why Portugal
A credible pathway to European pharmaceutical supply.
Portugal has an established regulatory pathway for medicinal cannabis, overseen by INFARMED. LVX BioTech is being developed to operate within that framework—giving industrial, technical, and distribution partners a clear, compliance-first basis for collaboration.
04 / The Team
Building a facility where science, operations, and compliance meet.
Founder biographies and specialist leadership profiles will be shared here as the project moves through its next development milestones.
Founder profiles
Details forthcoming
05 / Contact
Start a considered conversation.
For regulatory, engineering, facility, or distribution discussions, please get in touch with our team.
LVX BIOTECH
Part of the Luar do Côa group